Institutional shares held 78.3 Million
535K calls
523K puts
Total value of holdings $68.1M
$465K calls
$455K puts
Market Cap $188M
216,566,000 Shares Out.
Institutional ownership 36.15%
# of Institutions 125


Latest Institutional Activity in OCGN

Top Purchases

Q3 2024
Gmt Capital Corp Shares Held: 2.45M ($2.14M)
Q3 2024
Altium Capital Management LP Shares Held: 2.35M ($2.04M)
Q3 2024
Northern Trust Corp Shares Held: 2.18M ($1.9M)
Q3 2024
Vanguard Group Inc Shares Held: 16.9M ($14.7M)
Q3 2024
State Street Corp Shares Held: 15.8M ($13.8M)

Top Sells

Q3 2024
Rafferty Asset Management, LLC Shares Held: 797K ($694K)
Q3 2024
Group One Trading, L.P. Shares Held: 425K ($370K)
Q3 2024
New York State Common Retirement Fund Shares Held: 2.6K ($2.26K)
Q3 2024
Simplex Trading, LLC Shares Held: 91K ($79.1K)
Q3 2024
Price T Rowe Associates Inc Shares Held: 236K ($205K)

About OCGN

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410, gene therapy candidate for the treatment of dry age-related macular degeneration (AMD); and OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet AMD. Ocugen, Inc. has a strategic partnership with CanSino Biologics Inc. for gene therapy co-development and manufacturing; and Bharat Biotech for the commercialization of COVAXIN in the United States market. The company is headquartered in Malvern, Pennsylvania.


Insider Transactions at OCGN

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
35K Shares
From 2 Insiders
Open market or private purchase 35K shares
Sell / Disposition
224K Shares
From 2 Insiders
Payment of exercise price or tax liability 224K shares

Track Institutional and Insider Activities on OCGN

Follow Ocugen, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OCGN shares.

Notify only if

Insider Trading

Get notified when an Ocugen, Inc. insider buys or sells OCGN shares.

Notify only if

News

Receive news related to Ocugen, Inc.

Track Activities on OCGN